Skip to main content

Table 5 Comparison of Length of Inpatient Stay and Number of Hospitalizations After Switching to PP1M in Patients with ≥ 1 Inpatient Stay in Period A

From: A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China

 

Number of hospitalizations

Inpatient stays (days)

pre-PP1M

0.67±0.96

52.80±60.54

Post-PP1M

0.22±0.42

16.33±29.48

T

2.56

1.73

P

≤ 0.01

< 0.05